Signup Crypto ETF Stocks News

Tesla's Options Frenzy: What You Need to Know - Tesla ( NASDAQ:TSLA )

Deep-pocketed investors have adopted a bearish approach towards Tesla TSLA, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.

Source: www.benzinga.com
April 01, 2025 | 14:46:08
Category: News

Axsome's Solriamfetol Fails Primary Goal In Depression Study But Shows Improvements In Associated Sleep Disorder - Axsome Therapeutics ( NASDAQ:AXSM )

Solriamfetol did not meet the primary endpoint for MDD but showed benefits in patients with severe EDS. Axsome plans a new Phase 3 trial in 2025 focused on MDD patients with EDS. Feel unsure about the market's next move?

Source: www.benzinga.com
April 01, 2025 | 14:46:33
Category: News

Will AI Replace Us Or Redefine Us?

The conversation around artificial intelligence has shifted from speculative to urgent. With tools like ChatGPT writing emails, Midjourney designing ads, and machine learning powering everything from customer service to portfolio management, it's no longer a matter of if AI will impact human ...

Source: www.benzinga.com
April 01, 2025 | 14:49:58
Category: News

phaware® Launches Special Series of Podcast Episodes Spotlighting the Future of PH-ILD Treatment and Innovation

Liquidia, Pulmovant, and Gossamer Bio Partner with Nonprofit to Showcase Cutting-Edge Clinical Trials and Breakthrough Therapies

Source: www.benzinga.com
April 01, 2025 | 14:50:00
Category: News

WITH THE SOLARHK ACQUISITION COMPLETE, WANG & LEE GROUP WILL DRIVE HONG KONG'S RENEWABLE ENERGY FUTURE

Hong Kong, April 01, 2025 ( GLOBE NEWSWIRE ) -- WANG & LEE GROUP, Inc. ( NASDAQ: WLGS ) today announced the successful closing of its acquisition of Solar ( HK ) Limited ( "SolarHK" ) . The transaction, initially announced on March 3, 2025, has now been finalized, marking a transformative step in ...

Source: www.globenewswire.com
April 01, 2025 | 14:54:00
Category: News

Aquestive Therapeutics Concludes FDA Application For Allergy Drug With Encouraging Pediatric Trial Data - Aquestive Therapeutics ( NASDAQ:AQST )

Aquestive submitted Anaphylm's NDA to the FDA, expecting potential acceptance in Q2 2025, with a planned launch in Q1 2026 if approved. The pediatric study in 32 patients showed PK results consistent with adult data, with no serious adverse events reported.

Source: www.benzinga.com
April 01, 2025 | 14:54:06
Category: News

Waton Financial Limited Announces Pricing of Initial Public Offering

HONG KONG, April 01, 2025 ( GLOBE NEWSWIRE ) -- Waton Financial Limited ( "WTF" or the "Company" ) , a British Virgin Islands-incorporated holding company that provides of securities brokerage and financial technology services primarily through its Hong Kong subsidiaries, Waton Securities ...

Source: www.globenewswire.com
April 01, 2025 | 15:00:00
Category: News

Bitcoin's quantum-resistant hard fork is inevitable - It's the only chance to fix node incentives

Opinion by: Dr. Michael Tabone, senior economist for CointelegraphBitcoin ( BTC ) has long been hailed as unbreakable and untouchable, a digital stronghold against the forces of change. Bitcoin's bedrock of security is facing its first true test with quantum computing, which should be addressed ...

Source: cointelegraph.com
April 01, 2025 | 15:00:00
Category: News

Cylinder Celebrates 100,000 Members Served, Advancing Access to Digestive Healthcare

CHICAGO, April 01, 2025 ( GLOBE NEWSWIRE ) -- Cylinder, the leading virtual digestive health provider, today announced a major growth milestone of supporting over 100,000 members across all 50 states.

Source: www.benzinga.com
April 01, 2025 | 15:00:00
Category: News

Puzzles & Survival × TRANSFORMERS Team Up for Another Collaboration

WASHINGTON, April 1, 2025 /PRNewswire/ -- April 1st may be April Fool's Day-but this is no joke! 37GAMES's popular mobile game, Puzzles & Survival, is launching its second collaboration with the TRANSFORMERS bots! This time, fan-favorite Bumblebee joins the Commanders in their battle for survival!

Source: www.benzinga.com
April 01, 2025 | 15:00:00
Category: News

© Natavest 2025 - 2026